Thyroglobulin/thyrotropin ratio for predicting long-term response in differentiated thyroid carcinoma: a retrospective study

ABSTRACT Objective: Thyrotropin-stimulated thyroglobulin (STg) after total thyroidectomy is a prognosis marker for differentiated thyroid carcinoma (DTC). As Tg level is influenced by thyrotropin (TSH), perhaps the STg/TSH ratio is also a prognosis marker for these tumours. We aimed to compare STg/TSH ratio and first STg level in differentiated thyroid carcinoma patients for their ability to predict the long-term response to initial treatment. Subjects and methods: This retrospective study evaluated data from 181 DTC patients for first (1st) STg and STg/TSH ratio, at 1-3 months post-total thyroidectomy and before iodine-131 therapy, according to response to initial therapy [Excellent/Indeterminate or Incomplete (Biochemical/Structural)] observed at final evaluation, and with the survival time with excellent/indeterminate response. Results: Cases with incomplete response presented higher STg level [225.13 ± 585.26 ng/mL versus (vs) 20.4 ± 192.9 ng/mL; p < 0.001] and STg/TSH ratio (3.01 ± 7.8 vs 0.27 ± 2.58; p < 0.001). Cutoffs of 5 ng/mL for STg and 0.085 for STg/TSH displayed sensitivities of 76.7% and 76.9%, and specificities of 79.2% and 82.6%, respectively, in predicting response to therapy. Values below these cutoffs were associated with longer survival time in excellent/indeterminate response (140.4 vs 15.9 and 144.6 vs 15.9 months, respectively). Conclusion: STg/TSH ratio has a similar performance to the 1st STg in predicting long-term response to initial therapy.

Saved in:
Bibliographic Details
Main Authors: Marchi Junior,Adriano Francisco De, Macedo,Ana Bárbara Trizzotti de, Soares,Carlos Segundo Paiva, Bolfi,Fernanda, Iessi,Mariana Riello Gomes, Oliveira,Cristiano Claudino de, Koga,Katia Hiromoto, Moriguchi,Sonia Marta, Tagliarini,José Vicente, Mazeto,Gláucia Maria Ferreira da Silva
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Endocrinologia e Metabologia 2021
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000400428
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2359-39972021000400428
record_format ojs
spelling oai:scielo:S2359-399720210004004282021-09-16Thyroglobulin/thyrotropin ratio for predicting long-term response in differentiated thyroid carcinoma: a retrospective studyMarchi Junior,Adriano Francisco DeMacedo,Ana Bárbara Trizzotti deSoares,Carlos Segundo PaivaBolfi,FernandaIessi,Mariana Riello GomesOliveira,Cristiano Claudino deKoga,Katia HiromotoMoriguchi,Sonia MartaTagliarini,José VicenteMazeto,Gláucia Maria Ferreira da Silva Thyroid neoplasms thyroglobulin prognosis ABSTRACT Objective: Thyrotropin-stimulated thyroglobulin (STg) after total thyroidectomy is a prognosis marker for differentiated thyroid carcinoma (DTC). As Tg level is influenced by thyrotropin (TSH), perhaps the STg/TSH ratio is also a prognosis marker for these tumours. We aimed to compare STg/TSH ratio and first STg level in differentiated thyroid carcinoma patients for their ability to predict the long-term response to initial treatment. Subjects and methods: This retrospective study evaluated data from 181 DTC patients for first (1st) STg and STg/TSH ratio, at 1-3 months post-total thyroidectomy and before iodine-131 therapy, according to response to initial therapy [Excellent/Indeterminate or Incomplete (Biochemical/Structural)] observed at final evaluation, and with the survival time with excellent/indeterminate response. Results: Cases with incomplete response presented higher STg level [225.13 ± 585.26 ng/mL versus (vs) 20.4 ± 192.9 ng/mL; p < 0.001] and STg/TSH ratio (3.01 ± 7.8 vs 0.27 ± 2.58; p < 0.001). Cutoffs of 5 ng/mL for STg and 0.085 for STg/TSH displayed sensitivities of 76.7% and 76.9%, and specificities of 79.2% and 82.6%, respectively, in predicting response to therapy. Values below these cutoffs were associated with longer survival time in excellent/indeterminate response (140.4 vs 15.9 and 144.6 vs 15.9 months, respectively). Conclusion: STg/TSH ratio has a similar performance to the 1st STg in predicting long-term response to initial therapy.info:eu-repo/semantics/openAccessSociedade Brasileira de Endocrinologia e MetabologiaArchives of Endocrinology and Metabolism v.65 n.4 20212021-08-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000400428en10.20945/2359-3997000000387
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Marchi Junior,Adriano Francisco De
Macedo,Ana Bárbara Trizzotti de
Soares,Carlos Segundo Paiva
Bolfi,Fernanda
Iessi,Mariana Riello Gomes
Oliveira,Cristiano Claudino de
Koga,Katia Hiromoto
Moriguchi,Sonia Marta
Tagliarini,José Vicente
Mazeto,Gláucia Maria Ferreira da Silva
spellingShingle Marchi Junior,Adriano Francisco De
Macedo,Ana Bárbara Trizzotti de
Soares,Carlos Segundo Paiva
Bolfi,Fernanda
Iessi,Mariana Riello Gomes
Oliveira,Cristiano Claudino de
Koga,Katia Hiromoto
Moriguchi,Sonia Marta
Tagliarini,José Vicente
Mazeto,Gláucia Maria Ferreira da Silva
Thyroglobulin/thyrotropin ratio for predicting long-term response in differentiated thyroid carcinoma: a retrospective study
author_facet Marchi Junior,Adriano Francisco De
Macedo,Ana Bárbara Trizzotti de
Soares,Carlos Segundo Paiva
Bolfi,Fernanda
Iessi,Mariana Riello Gomes
Oliveira,Cristiano Claudino de
Koga,Katia Hiromoto
Moriguchi,Sonia Marta
Tagliarini,José Vicente
Mazeto,Gláucia Maria Ferreira da Silva
author_sort Marchi Junior,Adriano Francisco De
title Thyroglobulin/thyrotropin ratio for predicting long-term response in differentiated thyroid carcinoma: a retrospective study
title_short Thyroglobulin/thyrotropin ratio for predicting long-term response in differentiated thyroid carcinoma: a retrospective study
title_full Thyroglobulin/thyrotropin ratio for predicting long-term response in differentiated thyroid carcinoma: a retrospective study
title_fullStr Thyroglobulin/thyrotropin ratio for predicting long-term response in differentiated thyroid carcinoma: a retrospective study
title_full_unstemmed Thyroglobulin/thyrotropin ratio for predicting long-term response in differentiated thyroid carcinoma: a retrospective study
title_sort thyroglobulin/thyrotropin ratio for predicting long-term response in differentiated thyroid carcinoma: a retrospective study
description ABSTRACT Objective: Thyrotropin-stimulated thyroglobulin (STg) after total thyroidectomy is a prognosis marker for differentiated thyroid carcinoma (DTC). As Tg level is influenced by thyrotropin (TSH), perhaps the STg/TSH ratio is also a prognosis marker for these tumours. We aimed to compare STg/TSH ratio and first STg level in differentiated thyroid carcinoma patients for their ability to predict the long-term response to initial treatment. Subjects and methods: This retrospective study evaluated data from 181 DTC patients for first (1st) STg and STg/TSH ratio, at 1-3 months post-total thyroidectomy and before iodine-131 therapy, according to response to initial therapy [Excellent/Indeterminate or Incomplete (Biochemical/Structural)] observed at final evaluation, and with the survival time with excellent/indeterminate response. Results: Cases with incomplete response presented higher STg level [225.13 ± 585.26 ng/mL versus (vs) 20.4 ± 192.9 ng/mL; p < 0.001] and STg/TSH ratio (3.01 ± 7.8 vs 0.27 ± 2.58; p < 0.001). Cutoffs of 5 ng/mL for STg and 0.085 for STg/TSH displayed sensitivities of 76.7% and 76.9%, and specificities of 79.2% and 82.6%, respectively, in predicting response to therapy. Values below these cutoffs were associated with longer survival time in excellent/indeterminate response (140.4 vs 15.9 and 144.6 vs 15.9 months, respectively). Conclusion: STg/TSH ratio has a similar performance to the 1st STg in predicting long-term response to initial therapy.
publisher Sociedade Brasileira de Endocrinologia e Metabologia
publishDate 2021
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000400428
work_keys_str_mv AT marchijunioradrianofranciscode thyroglobulinthyrotropinratioforpredictinglongtermresponseindifferentiatedthyroidcarcinomaaretrospectivestudy
AT macedoanabarbaratrizzottide thyroglobulinthyrotropinratioforpredictinglongtermresponseindifferentiatedthyroidcarcinomaaretrospectivestudy
AT soarescarlossegundopaiva thyroglobulinthyrotropinratioforpredictinglongtermresponseindifferentiatedthyroidcarcinomaaretrospectivestudy
AT bolfifernanda thyroglobulinthyrotropinratioforpredictinglongtermresponseindifferentiatedthyroidcarcinomaaretrospectivestudy
AT iessimarianariellogomes thyroglobulinthyrotropinratioforpredictinglongtermresponseindifferentiatedthyroidcarcinomaaretrospectivestudy
AT oliveiracristianoclaudinode thyroglobulinthyrotropinratioforpredictinglongtermresponseindifferentiatedthyroidcarcinomaaretrospectivestudy
AT kogakatiahiromoto thyroglobulinthyrotropinratioforpredictinglongtermresponseindifferentiatedthyroidcarcinomaaretrospectivestudy
AT moriguchisoniamarta thyroglobulinthyrotropinratioforpredictinglongtermresponseindifferentiatedthyroidcarcinomaaretrospectivestudy
AT tagliarinijosevicente thyroglobulinthyrotropinratioforpredictinglongtermresponseindifferentiatedthyroidcarcinomaaretrospectivestudy
AT mazetoglauciamariaferreiradasilva thyroglobulinthyrotropinratioforpredictinglongtermresponseindifferentiatedthyroidcarcinomaaretrospectivestudy
_version_ 1756441470586322944